8 4
O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E | D E C E M B E R 2 0 1 4
says patients who have programmed intermittent boluses use less
anesthesia overall and have better pain scores and satisfaction rat-
ings. The price is the same as that of previous pumps, and the compa-
ny will upgrade their pumps to the next level for free.
smiths-medical.com
9
Eagle Pharmaceuticals Ryanodex
A Rapid Loading Dose for MH Emergencies
This product is a lot more
expensive than the alternative
dantrolene formulations, but
also much more convenient.
Traditionally, if you have a 100
kg patient in the midst of an MH
crisis, the first thing you do is
call for help, and that's for one
reason — to shake those darn
vials. With other dantrolene
products you'd need to reconsti-
tute 12 or 13 vials (at 20 g each)
just to get the loading dose. The
new product uses nanoparticle
technology to constitute the needed dose for a 100 kg patient (250
mg) in 1 vial that can be reconstituted in less than 60 seconds. But the
new product also has a shorter shelf life, which magnifies the added
cost (3 vials of Ryanodex will run you about $6,900, vs. about $3,000
for 36 vials of the alternative). Some will balk at the price, especially
since MH incidents are rare, but when you think about the patient, the
patient's family and the anesthesiologist, well, it's a tough call.
eagleus.com
F R O M T H E E X H I B I T H A L L
WHAT'S SHAKING A new dantrolene formula-
tion has distinct advantages and disadvantages.
